PATENT CLAIM ANALYSIS

Application Number: 16148414
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides vaccines for treating or preventing a herpes simplex virus infection and methods of using and making the vaccine. Further provided are recombinant herpes simplex virus genomes, recombinant viruses, and immunogenic compositions.

Claim (Index 10):
The vaccine of  claim 1 , further comprising a pharmaceutically acceptable component selected from the group consisting of a carrier, an excipient, a stabilizing agent, a preservative, an immunostimulant, and an adjuvant.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.25806
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15310004', '15455495', '12598937', '15928377', '15015322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.705802780765204
- 35 USC 102 Novelty (BERT): 0.7100071473890178
- Combined Prediction Score: 0.7062232174275854
- Mean Citation Score: 456.33795
- Max Citation Score: 796.5311
- Similarity Product: 724.5016302571892

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test